- Total raised
- $514M
- Stage
- Public
- Team size
- 11-50 employees
- Founded
- 2018
- HQ
- New York
About Lexeo Therapeutics
Advancing science with curative potential for both cardiovascular and APOE4 associated Alzheimer's disease areas.
Open roles · 4
- Open
Senior Director, Real World Evidence & Health Economics and Outcomes
New York, New York · hybrid · $265k–330k
- Open
Senior Manager/Associate Director, MSAT/Process Characterization and Validation Readiness (AAV)
New York, New York · hybrid · $176k–187k
- Open
Senior Scientist, Process Development (AAV)
New York, New York · hybrid · $151k–157k
- Open
Associate Director, Quality Systems and Compliance
New York, New York · hybrid · $176k–189k
Location
More startups in New York
Reflection
New York
Building superintelligent coding agents.
Polymarket
New York
Polymarket operates a blockchain-based marketplace where users trade on the outcomes of real-world events through prediction markets.
3Y Health
New York
3Y Health builds AI-driven software to empower providers and cut admin burden, enabling clinicians to launch practices. Backed by over $200M from Founders Fund, General Catalyst, SoftBank, and 8VC, it aims to cut admin complexity, about 40%
Tillman FiberCo
New York
The next generation of gigabit networks.
Profound
New York
Profound is a GenAI marketing intelligence platform for enterprise brands, delivering visibility analytics, competitive intelligence, and actionable insights across the GenAI ecosystem. It helps marketing teams optimize presence and gain co
OpenRouter
New York
LLM router and marketplace